Stelis and Syngene have executed the final agreements to transfer its Unit 3 multi-modal facility in Bengaluru to Syngene with gross consideration adjusted from Rs 702 crore to Rs 617 crore.
Strides Pharma gains on transfer of Bengaluru facility to Syngene on December 4, 2023 at 4:11 am
